Allotera Therapeutics has welcomed Aaron Vernon as Acting Chief Technology Officer, supporting the company’s technical ...
The BioHealth Capital Region earned national recognition with eight local companies named to TIME and Statista’s World’s Top ...
TEDCO, the Maryland Technology Development Corporation, announced on October 5, 2026 that it has accepted a Federal and State ...
Johns Hopkins Medicine and OpenEvidence, a medical AI platform for physicians, announced on October 13, 2026 a strategic collaboration to reimagine ...
BioBuzz’s Buzzin’ Brood Student Spotlight series celebrates the future of life sciences talent — and the programs, ...
The National Center to Accelerate Cures (NCAC) today, October 1, 2026 announced its official launch as a national initiative dedicated to advancing New Approach Methodologies (NAMs) toward regulatory ...
Citius Oncology, Inc., an oncology-focused biopharmaceutical company and majority-owned subsidiary of Citius Pharmaceuticals, Inc. (Nasdaq: CTXR), has appointed Jonathan Peri, Ph.D., J.D., as an ...
Elutia, the Gaithersburg, Maryland-based drug-eluting biomatrix company, announced it has completed the sale of its SimpliDerm® human acellular dermal matrix business to Cellution Biologics Inc. for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results